
|Videos|October 10, 2016
How Can Access to PCSK9 Inhibitors be Improved?
Author(s)Lauren Santye, Assistant Editor
Mark Tesell, PharmD, BCPS, clinical consultant pharmacist for UMass Medical School Clinical Pharmacy Services, discusses potential solutions for access to cholesterol lowering drugs to improve.
Advertisement
Mark Tesell, PharmD, BCPS, clinical consultant pharmacist for UMass Medical School Clinical Pharmacy Services, discusses potential solutions for access to cholesterol lowering drugs to improve.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Semaglutide Reduces Time in Spent in Hospital, Admission Rates in Patients With Overweight or Obesity
2
From the Pharmacy Counter to the Kitchen Cabinet: Helping Patients Choose Quality Supplements
3
Atebimetinib Signals a Potential Shift in First-Line Pancreatic Cancer Outcomes
4
Current Pneumococcal Vaccination Recommendations: A Clinical Update
5

























